CN114521652A - Composition with anti-aging effect and application thereof - Google Patents
Composition with anti-aging effect and application thereof Download PDFInfo
- Publication number
- CN114521652A CN114521652A CN202210160671.9A CN202210160671A CN114521652A CN 114521652 A CN114521652 A CN 114521652A CN 202210160671 A CN202210160671 A CN 202210160671A CN 114521652 A CN114521652 A CN 114521652A
- Authority
- CN
- China
- Prior art keywords
- parts
- extract
- composition
- aging effect
- schizophyllum commune
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000000203 mixture Substances 0.000 title claims abstract description 92
- 230000003712 anti-aging effect Effects 0.000 title claims abstract description 68
- 241000222481 Schizophyllum commune Species 0.000 claims abstract description 71
- 102000008186 Collagen Human genes 0.000 claims abstract description 19
- 108010035532 Collagen Proteins 0.000 claims abstract description 19
- 229920001436 collagen Polymers 0.000 claims abstract description 19
- 239000000419 plant extract Substances 0.000 claims abstract description 19
- 108090000765 processed proteins & peptides Proteins 0.000 claims abstract description 17
- 239000000284 extract Substances 0.000 claims description 55
- 238000002360 preparation method Methods 0.000 claims description 54
- 235000013361 beverage Nutrition 0.000 claims description 38
- 238000000855 fermentation Methods 0.000 claims description 35
- 230000004151 fermentation Effects 0.000 claims description 35
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 34
- 238000002156 mixing Methods 0.000 claims description 31
- 239000005913 Maltodextrin Substances 0.000 claims description 23
- 229920002774 Maltodextrin Polymers 0.000 claims description 23
- 229940035034 maltodextrin Drugs 0.000 claims description 23
- 239000007788 liquid Substances 0.000 claims description 22
- 238000000605 extraction Methods 0.000 claims description 20
- 239000007787 solid Substances 0.000 claims description 19
- 239000002994 raw material Substances 0.000 claims description 18
- 238000001914 filtration Methods 0.000 claims description 16
- 238000001694 spray drying Methods 0.000 claims description 16
- 240000007817 Olea europaea Species 0.000 claims description 14
- 239000000796 flavoring agent Substances 0.000 claims description 14
- 235000013355 food flavoring agent Nutrition 0.000 claims description 13
- 239000002904 solvent Substances 0.000 claims description 11
- 240000005662 Aronia melanocarpa Species 0.000 claims description 9
- 235000007425 Aronia melanocarpa Nutrition 0.000 claims description 9
- 235000013399 edible fruits Nutrition 0.000 claims description 9
- 238000011049 filling Methods 0.000 claims description 9
- 230000001954 sterilising effect Effects 0.000 claims description 9
- 244000119298 Emblica officinalis Species 0.000 claims description 8
- 235000015489 Emblica officinalis Nutrition 0.000 claims description 8
- 235000019216 blueberry extract Nutrition 0.000 claims description 8
- 229940055416 blueberry extract Drugs 0.000 claims description 8
- 239000000463 material Substances 0.000 claims description 8
- 239000012528 membrane Substances 0.000 claims description 8
- 241000196324 Embryophyta Species 0.000 claims description 7
- 235000020237 cranberry extract Nutrition 0.000 claims description 7
- 238000012258 culturing Methods 0.000 claims description 7
- 238000000034 method Methods 0.000 claims description 7
- 238000001035 drying Methods 0.000 claims description 6
- 238000004806 packaging method and process Methods 0.000 claims description 6
- 239000002245 particle Substances 0.000 claims description 6
- 238000004659 sterilization and disinfection Methods 0.000 claims description 6
- 238000005516 engineering process Methods 0.000 claims description 5
- 235000011389 fruit/vegetable juice Nutrition 0.000 claims description 5
- 235000013402 health food Nutrition 0.000 claims description 5
- 238000005469 granulation Methods 0.000 claims description 4
- 230000003179 granulation Effects 0.000 claims description 4
- 238000003756 stirring Methods 0.000 claims description 4
- 240000002547 Rosa roxburghii Species 0.000 claims description 3
- 235000000640 Rosa roxburghii Nutrition 0.000 claims description 3
- 150000001450 anions Chemical class 0.000 claims description 3
- 238000004140 cleaning Methods 0.000 claims description 3
- 238000007873 sieving Methods 0.000 claims description 3
- 235000015203 fruit juice Nutrition 0.000 claims description 2
- 239000008202 granule composition Substances 0.000 claims description 2
- PMMYEEVYMWASQN-DMTCNVIQSA-N Hydroxyproline Chemical compound O[C@H]1CN[C@H](C(O)=O)C1 PMMYEEVYMWASQN-DMTCNVIQSA-N 0.000 abstract description 19
- PMMYEEVYMWASQN-UHFFFAOYSA-N dl-hydroxyproline Natural products OC1C[NH2+]C(C([O-])=O)C1 PMMYEEVYMWASQN-UHFFFAOYSA-N 0.000 abstract description 19
- 229960002591 hydroxyproline Drugs 0.000 abstract description 19
- FGMPLJWBKKVCDB-UHFFFAOYSA-N trans-L-hydroxy-proline Natural products ON1CCCC1C(O)=O FGMPLJWBKKVCDB-UHFFFAOYSA-N 0.000 abstract description 19
- KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 abstract description 16
- 229920002674 hyaluronan Polymers 0.000 abstract description 16
- 229960003160 hyaluronic acid Drugs 0.000 abstract description 16
- 230000000694 effects Effects 0.000 abstract description 14
- 102000004127 Cytokines Human genes 0.000 abstract description 13
- 108090000695 Cytokines Proteins 0.000 abstract description 13
- 108090000790 Enzymes Proteins 0.000 abstract description 10
- 102000004190 Enzymes Human genes 0.000 abstract description 10
- 239000003963 antioxidant agent Substances 0.000 abstract description 10
- 230000003078 antioxidant effect Effects 0.000 abstract description 10
- 230000002757 inflammatory effect Effects 0.000 abstract description 7
- 230000028327 secretion Effects 0.000 abstract description 6
- 230000002401 inhibitory effect Effects 0.000 abstract description 4
- 230000007246 mechanism Effects 0.000 abstract description 3
- 230000009471 action Effects 0.000 abstract description 2
- 239000000047 product Substances 0.000 description 48
- 238000012360 testing method Methods 0.000 description 43
- 239000000523 sample Substances 0.000 description 26
- 239000000243 solution Substances 0.000 description 24
- 230000000052 comparative effect Effects 0.000 description 23
- 238000002835 absorbance Methods 0.000 description 18
- 239000001963 growth medium Substances 0.000 description 15
- 210000004027 cell Anatomy 0.000 description 13
- 210000003491 skin Anatomy 0.000 description 13
- 239000012228 culture supernatant Substances 0.000 description 8
- 230000005764 inhibitory process Effects 0.000 description 8
- 230000000770 proinflammatory effect Effects 0.000 description 8
- 150000003254 radicals Chemical class 0.000 description 8
- 241000252212 Danio rerio Species 0.000 description 7
- 102000013462 Interleukin-12 Human genes 0.000 description 7
- 108010065805 Interleukin-12 Proteins 0.000 description 7
- 102000004889 Interleukin-6 Human genes 0.000 description 7
- 108090001005 Interleukin-6 Proteins 0.000 description 7
- RWSXRVCMGQZWBV-WDSKDSINSA-N glutathione Chemical compound OC(=O)[C@@H](N)CCC(=O)N[C@@H](CS)C(=O)NCC(O)=O RWSXRVCMGQZWBV-WDSKDSINSA-N 0.000 description 7
- 239000000843 powder Substances 0.000 description 7
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 6
- 241000699670 Mus sp. Species 0.000 description 6
- 241000220317 Rosa Species 0.000 description 6
- HHEAADYXPMHMCT-UHFFFAOYSA-N dpph Chemical compound [O-][N+](=O)C1=CC([N+](=O)[O-])=CC([N+]([O-])=O)=C1[N]N(C=1C=CC=CC=1)C1=CC=CC=C1 HHEAADYXPMHMCT-UHFFFAOYSA-N 0.000 description 6
- 238000010998 test method Methods 0.000 description 6
- -1 DPPH free radical Chemical class 0.000 description 5
- 244000046146 Pueraria lobata Species 0.000 description 5
- 235000010575 Pueraria lobata Nutrition 0.000 description 5
- 108060008682 Tumor Necrosis Factor Proteins 0.000 description 5
- 102000000852 Tumor Necrosis Factor-alpha Human genes 0.000 description 5
- 239000002609 medium Substances 0.000 description 5
- 238000010186 staining Methods 0.000 description 5
- 238000002965 ELISA Methods 0.000 description 4
- WSMYVTOQOOLQHP-UHFFFAOYSA-N Malondialdehyde Chemical compound O=CCC=O WSMYVTOQOOLQHP-UHFFFAOYSA-N 0.000 description 4
- 241000699666 Mus <mouse, genus> Species 0.000 description 4
- 230000032683 aging Effects 0.000 description 4
- 238000002474 experimental method Methods 0.000 description 4
- 210000002950 fibroblast Anatomy 0.000 description 4
- 235000003599 food sweetener Nutrition 0.000 description 4
- 229940118019 malondialdehyde Drugs 0.000 description 4
- 230000003647 oxidation Effects 0.000 description 4
- 238000007254 oxidation reaction Methods 0.000 description 4
- 238000011160 research Methods 0.000 description 4
- 239000012488 sample solution Substances 0.000 description 4
- 239000003381 stabilizer Substances 0.000 description 4
- 239000000126 substance Substances 0.000 description 4
- 239000003765 sweetening agent Substances 0.000 description 4
- 239000006144 Dulbecco’s modified Eagle's medium Substances 0.000 description 3
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 3
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 3
- 241001465754 Metazoa Species 0.000 description 3
- 230000002292 Radical scavenging effect Effects 0.000 description 3
- OUUQCZGPVNCOIJ-UHFFFAOYSA-M Superoxide Chemical compound [O-][O] OUUQCZGPVNCOIJ-UHFFFAOYSA-M 0.000 description 3
- 240000000851 Vaccinium corymbosum Species 0.000 description 3
- 235000003095 Vaccinium corymbosum Nutrition 0.000 description 3
- 240000001717 Vaccinium macrocarpon Species 0.000 description 3
- 235000012545 Vaccinium macrocarpon Nutrition 0.000 description 3
- 235000017537 Vaccinium myrtillus Nutrition 0.000 description 3
- 235000002118 Vaccinium oxycoccus Nutrition 0.000 description 3
- 235000021014 blueberries Nutrition 0.000 description 3
- 229940041514 candida albicans extract Drugs 0.000 description 3
- 239000013068 control sample Substances 0.000 description 3
- 239000002537 cosmetic Substances 0.000 description 3
- 235000004634 cranberry Nutrition 0.000 description 3
- 230000016396 cytokine production Effects 0.000 description 3
- 238000004043 dyeing Methods 0.000 description 3
- 238000011156 evaluation Methods 0.000 description 3
- 239000008103 glucose Substances 0.000 description 3
- 229960003180 glutathione Drugs 0.000 description 3
- 238000010438 heat treatment Methods 0.000 description 3
- TUJKJAMUKRIRHC-UHFFFAOYSA-N hydroxyl Chemical compound [OH] TUJKJAMUKRIRHC-UHFFFAOYSA-N 0.000 description 3
- 229910052943 magnesium sulfate Inorganic materials 0.000 description 3
- 235000019341 magnesium sulphate Nutrition 0.000 description 3
- 229910000402 monopotassium phosphate Inorganic materials 0.000 description 3
- 235000019796 monopotassium phosphate Nutrition 0.000 description 3
- 239000002504 physiological saline solution Substances 0.000 description 3
- 239000008213 purified water Substances 0.000 description 3
- 230000002000 scavenging effect Effects 0.000 description 3
- 210000002966 serum Anatomy 0.000 description 3
- 230000002195 synergetic effect Effects 0.000 description 3
- 239000006188 syrup Substances 0.000 description 3
- 235000020357 syrup Nutrition 0.000 description 3
- 235000019640 taste Nutrition 0.000 description 3
- 239000012138 yeast extract Substances 0.000 description 3
- WDQLRUYAYXDIFW-RWKIJVEZSA-N (2r,3r,4s,5r,6r)-4-[(2s,3r,4s,5r,6r)-3,5-dihydroxy-4-[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-6-[[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxymethyl]oxan-2-yl]oxy-6-(hydroxymethyl)oxane-2,3,5-triol Chemical group O[C@@H]1[C@@H](CO)O[C@@H](O)[C@H](O)[C@H]1O[C@H]1[C@H](O)[C@@H](O[C@H]2[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O2)O)[C@H](O)[C@@H](CO[C@H]2[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O2)O)O1 WDQLRUYAYXDIFW-RWKIJVEZSA-N 0.000 description 2
- QKNYBSVHEMOAJP-UHFFFAOYSA-N 2-amino-2-(hydroxymethyl)propane-1,3-diol;hydron;chloride Chemical compound Cl.OCC(N)(CO)CO QKNYBSVHEMOAJP-UHFFFAOYSA-N 0.000 description 2
- 241000251468 Actinopterygii Species 0.000 description 2
- 108091003079 Bovine Serum Albumin Proteins 0.000 description 2
- 238000008157 ELISA kit Methods 0.000 description 2
- 229920002305 Schizophyllan Polymers 0.000 description 2
- 239000004480 active ingredient Substances 0.000 description 2
- 230000003064 anti-oxidating effect Effects 0.000 description 2
- 238000006243 chemical reaction Methods 0.000 description 2
- 239000008367 deionised water Substances 0.000 description 2
- 229910021641 deionized water Inorganic materials 0.000 description 2
- 238000001514 detection method Methods 0.000 description 2
- 238000011161 development Methods 0.000 description 2
- 230000018109 developmental process Effects 0.000 description 2
- 238000007865 diluting Methods 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 230000002500 effect on skin Effects 0.000 description 2
- 239000012091 fetal bovine serum Substances 0.000 description 2
- 235000013305 food Nutrition 0.000 description 2
- 150000004676 glycans Chemical class 0.000 description 2
- 239000000411 inducer Substances 0.000 description 2
- 229940117681 interleukin-12 Drugs 0.000 description 2
- 229940100601 interleukin-6 Drugs 0.000 description 2
- 230000003287 optical effect Effects 0.000 description 2
- PJNZPQUBCPKICU-UHFFFAOYSA-N phosphoric acid;potassium Chemical compound [K].OP(O)(O)=O PJNZPQUBCPKICU-UHFFFAOYSA-N 0.000 description 2
- 229920001282 polysaccharide Polymers 0.000 description 2
- 239000005017 polysaccharide Substances 0.000 description 2
- 230000008092 positive effect Effects 0.000 description 2
- WQGWDDDVZFFDIG-UHFFFAOYSA-N pyrogallol Chemical compound OC1=CC=CC(O)=C1O WQGWDDDVZFFDIG-UHFFFAOYSA-N 0.000 description 2
- YGSDEFSMJLZEOE-UHFFFAOYSA-N salicylic acid Chemical compound OC(=O)C1=CC=CC=C1O YGSDEFSMJLZEOE-UHFFFAOYSA-N 0.000 description 2
- 210000000582 semen Anatomy 0.000 description 2
- 238000003860 storage Methods 0.000 description 2
- GOZMBJCYMQQACI-UHFFFAOYSA-N 6,7-dimethyl-3-[[methyl-[2-[methyl-[[1-[3-(trifluoromethyl)phenyl]indol-3-yl]methyl]amino]ethyl]amino]methyl]chromen-4-one;dihydrochloride Chemical compound Cl.Cl.C=1OC2=CC(C)=C(C)C=C2C(=O)C=1CN(C)CCN(C)CC(C1=CC=CC=C11)=CN1C1=CC=CC(C(F)(F)F)=C1 GOZMBJCYMQQACI-UHFFFAOYSA-N 0.000 description 1
- 244000221226 Armillaria mellea Species 0.000 description 1
- 235000011569 Armillaria mellea Nutrition 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- 241001313708 Dictyophora phalloidea Species 0.000 description 1
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 1
- 235000021559 Fruit Juice Concentrate Nutrition 0.000 description 1
- 241000233866 Fungi Species 0.000 description 1
- 108010024636 Glutathione Proteins 0.000 description 1
- 240000001080 Grifola frondosa Species 0.000 description 1
- 235000007710 Grifola frondosa Nutrition 0.000 description 1
- 240000000588 Hericium erinaceus Species 0.000 description 1
- 235000007328 Hericium erinaceus Nutrition 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 241000117280 Naematelia aurantialba Species 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 244000197580 Poria cocos Species 0.000 description 1
- 235000008599 Poria cocos Nutrition 0.000 description 1
- 241000219780 Pueraria Species 0.000 description 1
- 102000004142 Trypsin Human genes 0.000 description 1
- 108090000631 Trypsin Proteins 0.000 description 1
- 240000008866 Ziziphus nummularia Species 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 230000004913 activation Effects 0.000 description 1
- 239000013543 active substance Substances 0.000 description 1
- 230000010398 acute inflammatory response Effects 0.000 description 1
- 238000010171 animal model Methods 0.000 description 1
- 230000003796 beauty Effects 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 108010005774 beta-Galactosidase Proteins 0.000 description 1
- 235000019658 bitter taste Nutrition 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 239000002131 composite material Substances 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 230000001419 dependent effect Effects 0.000 description 1
- 230000001079 digestive effect Effects 0.000 description 1
- MGJZITXUQXWAKY-UHFFFAOYSA-N diphenyl-(2,4,6-trinitrophenyl)iminoazanium Chemical compound [O-][N+](=O)C1=CC([N+](=O)[O-])=CC([N+]([O-])=O)=C1N=[N+](C=1C=CC=CC=1)C1=CC=CC=C1 MGJZITXUQXWAKY-UHFFFAOYSA-N 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 239000012894 fetal calf serum Substances 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- 239000003205 fragrance Substances 0.000 description 1
- 235000020510 functional beverage Nutrition 0.000 description 1
- 239000006481 glucose medium Substances 0.000 description 1
- 239000008187 granular material Substances 0.000 description 1
- 239000003102 growth factor Substances 0.000 description 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 1
- 238000010191 image analysis Methods 0.000 description 1
- 238000003384 imaging method Methods 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 238000011534 incubation Methods 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 230000028709 inflammatory response Effects 0.000 description 1
- 238000011081 inoculation Methods 0.000 description 1
- 239000002054 inoculum Substances 0.000 description 1
- 238000002372 labelling Methods 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 239000011159 matrix material Substances 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 230000000813 microbial effect Effects 0.000 description 1
- 239000011812 mixed powder Substances 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 238000001543 one-way ANOVA Methods 0.000 description 1
- 239000013588 oral product Substances 0.000 description 1
- 239000003960 organic solvent Substances 0.000 description 1
- FJKROLUGYXJWQN-UHFFFAOYSA-N papa-hydroxy-benzoic acid Natural products OC(=O)C1=CC=C(O)C=C1 FJKROLUGYXJWQN-UHFFFAOYSA-N 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 239000011148 porous material Substances 0.000 description 1
- GNSKLFRGEWLPPA-UHFFFAOYSA-M potassium dihydrogen phosphate Chemical compound [K+].OP(O)([O-])=O GNSKLFRGEWLPPA-UHFFFAOYSA-M 0.000 description 1
- LWIHDJKSTIGBAC-UHFFFAOYSA-K potassium phosphate Substances [K+].[K+].[K+].[O-]P([O-])([O-])=O LWIHDJKSTIGBAC-UHFFFAOYSA-K 0.000 description 1
- 239000002244 precipitate Substances 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 230000006318 protein oxidation Effects 0.000 description 1
- 229940079877 pyrogallol Drugs 0.000 description 1
- 230000005855 radiation Effects 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 229960004889 salicylic acid Drugs 0.000 description 1
- 210000004927 skin cell Anatomy 0.000 description 1
- 210000001626 skin fibroblast Anatomy 0.000 description 1
- 239000002002 slurry Substances 0.000 description 1
- 239000012086 standard solution Substances 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- 239000006228 supernatant Substances 0.000 description 1
- 235000019605 sweet taste sensations Nutrition 0.000 description 1
- 230000008961 swelling Effects 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 239000002562 thickening agent Substances 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 239000012588 trypsin Substances 0.000 description 1
- 229910021642 ultra pure water Inorganic materials 0.000 description 1
- 239000012498 ultrapure water Substances 0.000 description 1
- 230000008728 vascular permeability Effects 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/105—Plant extracts, their artificial duplicates or their derivatives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
- A23L2/02—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation containing fruit or vegetable juices
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
- A23L2/385—Concentrates of non-alcoholic beverages
- A23L2/39—Dry compositions
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L31/00—Edible extracts or preparations of fungi; Preparation or treatment thereof
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/17—Amino acids, peptides or proteins
- A23L33/18—Peptides; Protein hydrolysates
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P19/00—Preparation of compounds containing saccharide radicals
- C12P19/04—Polysaccharides, i.e. compounds containing more than five saccharide radicals attached to each other by glycosidic bonds
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Nutrition Science (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Mycology (AREA)
- Organic Chemistry (AREA)
- Zoology (AREA)
- Microbiology (AREA)
- Wood Science & Technology (AREA)
- Biotechnology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Molecular Biology (AREA)
- Botany (AREA)
- Biochemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Cosmetics (AREA)
Abstract
The invention provides a composition with an anti-aging effect and application thereof. The composition with anti-aging effect comprises: schizophyllum commune fermented product, plant extract and collagen peptide. The mechanism of the action of the composition on the aged skin is found to be capable of increasing the contents of hydroxyproline and hyaluronic acid in the skin, improving the activity of antioxidant enzymes of a mouse body and inhibiting the secretion of inflammatory cytokines.
Description
Technical Field
The invention belongs to the technical field of health-care food, and particularly relates to a composition with an anti-aging effect and application thereof.
Background
Schizophyllum commune is a precious edible fungus, and the main active substance in the fruiting body, mycelium and fermentation liquor is schizophyllan. Research shows that the compound has pharmacological activities of resisting tumor, bacteria and radiation, improving immunity and the like.
The main application in oral health food is Schizophyllum commune fruiting body extract. However, the wild schizophyllum commune is precious, so that the yield of the artificially cultured sporocarp is limited, and the application range of the wild schizophyllum commune is directly influenced. Meanwhile, the Schizophyllum commune extract is dark in color and has limitations in application to oral products. Although the Schizophyllum commune fermented product (Schizophyllum commune polysaccharide) has application in cosmetics, the application of the Schizophyllum commune fermented product in oral cosmetic products is not seen.
CN113337545A discloses a Schizophyllum commune fermentation product, a preparation method thereof, a skin care product and a Schizophyllum commune culture medium. In particular to a Schizophyllum commune fermentation product, a preparation method thereof, a skin care product and a Schizophyllum commune culture medium. The preparation method of the Schizophyllum commune fermentation product comprises the following steps: culturing Schizophyllum commune in Schizophyllum commune culture medium, and collecting fermentation product; wherein the schizophyllum commune culture medium contains kudzu root. Pueraria powder is added into a culture medium to culture Schizophyllum commune, and a fermentation product is collected, wherein the obtained fermentation product has positive effects on oxidation resistance and free radical removal.
CN107320541A discloses Schizophyllum commune semen ziziphi spinosae syrup and a preparation process thereof, wherein the syrup consists of Schizophyllum commune fermentation liquor, semen ziziphi spinosae extract, a sweetening agent, an acidity regulator, deionized water and a stabilizing agent, and the components are in parts by weight and the addition ratio are as follows: 35-40 parts of schizophyllum commune fermentation liquor, 25-30 parts of spina date seed extracting solution, 5-8 parts of sweetening agent, 0.5-1 part of sour agent, 330 parts of deionized water and 350 parts of stabilizing agent and 1-2 parts of stabilizing agent. The invention adopts the schizophyllum commune fermentation liquor and the wild jujube seed extract to directly prepare the product, avoids the toxic and side effects of the residual organic solvent, is more acceptable to patients when taking the syrup than special medicine taking, can achieve the treatment effect while enjoying the delicious food, and has great economic value and development potential.
CN106173661A discloses a composite strain mixed fermentation functional beverage and a preparation method thereof, wherein each 1000mL of purified water contains: 9-15 g of poria cocos, 10-30 g of dictyophora phalloidea, 6-12 g of tremella aurantialba, 10-20 g of grifola frondosa, 10-30 g of hericium erinaceus, 30-60 g of armillaria mellea, 9-16 g of schizophyllum commune, 1-5 g of sweetening agent, 0.1-0.5 g of acidity regulator, and 0.1-0.5 g of thickening agent and stabilizing agent. The solid content is not less than 10 percent, the total acid content is less than 1.0 percent, the color is yellow brown, uniform and consistent, the precipitate is not easy to occur after long-term storage, the special fragrance and taste of fermentation are provided, the sweet and bitter taste is appropriate, the taste is fine and harmonious, the mouthfeel is full, and the style is unique and pure.
Therefore, the development of a Schizophyllum commune fermented product for use in an oral cosmetic product is a research focus in the field.
Disclosure of Invention
Aiming at the defects of the prior art, the invention aims to provide a composition with an anti-aging effect and application thereof. The mechanism of the composition on the aging skin is found to be capable of increasing the contents of hydroxyproline and hyaluronic acid in the skin, improving the activity of antioxidant enzymes of a mouse body and inhibiting the secretion of inflammatory cytokines.
In order to achieve the purpose, the invention adopts the following technical scheme:
in a first aspect, the present invention provides a composition having anti-aging effect, comprising: schizophyllum commune fermented product, plant extract and collagen peptide.
In the invention, the Schizophyllum commune fermentation product, the plant extract and the collagen peptide are mutually matched, so that the Schizophyllum commune fermentation product has a synergistic effect, has an anti-aging effect on skin, can obviously improve the contents of hydroxyproline and hyaluronic acid in the skin, improves the activity of antioxidant enzymes of a mouse body, and has an inhibition effect on inflammatory cytokine secretion.
Preferably, the composition with the anti-aging effect comprises the following components in parts by weight: 20-40 parts of schizophyllum commune fermentation product, 3-10 parts of plant extract and 7-16 parts of collagen peptide.
The content of the Schizophyllum commune fermented product in the composition is 20-40 parts, such as 20 parts, 22 parts, 24 parts, 26 parts, 28 parts, 30 parts, 32 parts, 34 parts, 36 parts, 38 parts, 40 parts and the like.
In the composition, the plant extract content is 3-10 parts, and may be, for example, 3 parts, 4 parts, 5 parts, 6 parts, 7 parts, 8 parts, 9 parts, 10 parts, etc.
In the composition, the collagen peptide is contained in an amount of 7 to 16 parts, for example, 7 parts, 8 parts, 9 parts, 10 parts, 11 parts, 12 parts, 13 parts, 14 parts, 15 parts, 16 parts, etc.
Preferably, the Schizophyllum commune fermented product is obtained by culturing Schizophyllum commune in a medium containing radix Puerariae.
Wherein the Schizophyllum commune fermented product CN113337545A is prepared by the preparation method disclosed by the patent specification. It has positive effects in resisting oxidation and scavenging free radicals. The provided Schizophyllum commune fermentation product contains Schizophyllum commune polysaccharide as an active ingredient, and shows better capabilities in the aspects of removing excessive free radicals and inhibiting related enzyme activities by combining the antioxidant capacity of the radix puerariae matrix.
The raw material sources and the preparation method of the schizophyllum commune fermentation product are as follows:
firstly, a schizophyllum commune culture medium: 2-8g/L of kudzu root powder (less than or equal to 40 meshes), 0.1-0.5 wt% of yeast extract, 0.01-0.15 wt% of magnesium sulfate, 0.05-0.2 wt% of potassium dihydrogen phosphate, 1-4 wt% of glucose and the balance of water.
In the schizophyllum commune medium, the particle size of the pueraria lobata powder is not more than 40 meshes, and may be, for example, 40 meshes, 35 meshes, 30 meshes, 25 meshes, 20 meshes, 15 meshes, 10 meshes, 5 meshes, 2 meshes, 1 mesh, or the like.
In the schizophyllum commune culture medium, the content of the kudzu root powder is 2-8g/L, for example, 2g/L, 2.5g/L, 3g/L, 3.5g/L, 4g/L, 4.5g/L, 5g/L, 5.5g/L, 6g/L, 6.5g/L, 7g/L, 7.5g/L, 8g/L, etc.
The content of the yeast extract in the Schizophyllum commune culture medium is 0.1-0.5 wt%, and may be, for example, 0.1 wt%, 0.2 wt%, 0.3 wt%, 0.4 wt%, 0.5 wt%, or the like.
The magnesium sulfate content in the Schizophyllum commune culture medium is 0.01-0.15 wt%, and may be, for example, 0.01 wt%, 0.02 wt%, 0.04 wt%, 0.06 wt%, 0.08 wt%, 0.1 wt%, 0.12 wt%, 0.14 wt%, 0.15 wt%, or the like.
In the Schizophyllum commune culture medium, the content of potassium dihydrogen phosphate is 0.05-0.2 wt%, and may be, for example, 0.05 wt%, 0.06 wt%, 0.08 wt%, 0.1 wt%, 0.12 wt%, 0.14 wt%, 0.16 wt%, 0.18 wt%, 0.2 wt%, etc.
The amount of glucose in the Schizophyllum commune medium is 1-4 wt%, and may be, for example, 1 wt%, 2 wt%, 3 wt%, 4 wt%, etc.
② fermentation culture: performing activated culture on Schizophyllum commune strain (GIM 5.43 provided by Guangdong province microbial research institute) to obtain Schizophyllum commune; then 10% of Schizophyllum commune (v/v, Schizophyllum commune seed solution/total volume of the culture medium after seed solution inoculation) is inoculated into the culture medium, and fermentation culture is carried out for 100-150h (for example, 100h, 110h, 120h, 130h, 140h, 150h and the like) under the conditions of 28-30 ℃ (for example, 28 ℃, 29 ℃, 30 ℃ and the like), 140-170r/min (for example, 140r/min, 150r/min, and the like).
Preparing fermentation liquor: and (4) stopping centrifuging the fermentation product, separating the thallus from the fermentation liquor, and obtaining supernatant as the fermentation liquor.
Preferably, the plant extract comprises any one or a combination of at least two of olive extract, roxburgh rose extract, emblic leafflower fruit extract, blueberry extract, cranberry extract or aronia melanocarpa extract.
Preferably, the plant extract is obtained by PEF extraction.
Preferably, the plant extract is prepared by the following preparation method:
(a) extracting the plant raw materials by using water as a solvent through a PEF extraction method to obtain a plant extracting solution;
(b) filtering and concentrating the plant extract obtained in the step (a) to obtain an extract;
(c) and (c) mixing the extract obtained in the step (b) with maltodextrin, and then carrying out spray drying to obtain the plant extract.
Preferably, in step (a), the mass-to-volume ratio of the plant material to water is 1 (10-30) g/mL, for example, the ratio of the mass of the plant material to water may be 1g/10mL, 1g/15mL, 1g/20mL, 1g/25mL, 1g/30mL, or the like.
Preferably, in step (a), the field strength of the extraction is 10-30kV/cm, such as 10kV/cm, 15kV/cm, 20kV/cm, 25kV/cm, 30kV/cm, etc., and the number of pulses of the extraction is 4-12, such as 4, 5, 6, 7, 8, 9, 10, 11, 12, etc.
Preferably, in step (b), 200-300 mesh filter membranes are used for filtration, and can be 200 meshes, 220 meshes, 240 meshes, 260 meshes, 280 meshes, 300 meshes and the like.
Preferably, in step (b), the concentration temperature is 70-90 deg.C, such as 70 deg.C, 75 deg.C, 80 deg.C, 85 deg.C, 90 deg.C.
Preferably, in the step (c), the mass ratio of the extract to the maltodextrin is 1 (0.05-0.4), and may be 1:0.05, 1:0.1, 1:0.15, 1:0.2, 1:0.25, 1:0.3, 1:0.35, 1:0.4, etc.
Preferably, in step (c), the air inlet temperature for spray drying is 85-120 deg.C, such as 85 deg.C, 90 deg.C, 95 deg.C, 100 deg.C, 105 deg.C, 110 deg.C, 115 deg.C, 120 deg.C, etc., and the air outlet temperature is 65-90 deg.C, such as 65 deg.C, 70 deg.C, 75 deg.C, 80 deg.C, 85 deg.C, 90 deg.C, etc.
In a second aspect, the present invention provides the use of a composition having anti-aging effects as described in the first aspect in the preparation of a health food.
Preferably, the health food comprises a solid beverage and/or a liquid beverage.
In a third aspect, the present invention provides a solid beverage comprising the composition having anti-aging effect according to the first aspect.
Preferably, the solid beverage comprises the following components in parts by weight: 20-40 parts of the composition with the anti-aging effect, 0-1 part of a flavoring agent, 0-4.5 parts of edible essence and 15-30 parts of maltodextrin.
In the solid beverage, the content of the composition having an anti-aging effect is 20 to 40 parts, and may be, for example, 20 parts, 22 parts, 24 parts, 26 parts, 28 parts, 30 parts, 32 parts, 34 parts, 36 parts, 38 parts, 40 parts, and the like.
The flavoring agent may be contained in the solid beverage in an amount of 0 to 1 part, and may be, for example, 0 part, 0.1 part, 0.2 part, 0.4 part, 0.6 part, 0.8 part, 1 part, or the like.
In the solid beverage, the content of the flavoring essence is 0-4.5 parts, for example, 0 part, 0.1 part, 0.2 part, 0.4 part, 0.6 part, 0.8 part, 1 part, 1.2 parts, 1.5 parts, 2 parts, 2.5 parts, 3 parts, 3.5 parts, 4 parts, 4.5 parts and the like.
In the solid beverage, the content of the maltodextrin is 15 to 30 parts, and may be, for example, 15 parts, 16 parts, 18 parts, 20 parts, 22 parts, 24 parts, 26 parts, 28 parts, 30 parts, or the like.
In a fourth aspect, the present invention provides a method for preparing a solid beverage as described in the third aspect, specifically comprising the following steps:
(1) mixing the plant extract and maltodextrin, mixing with Schizophyllum commune fermented product, and granulating to obtain granule mixture;
(2) and (2) drying the particle mixture obtained in the step (1), and then totally mixing the particle mixture with collagen peptide, optional flavoring agent and optional flavoring essence to obtain the solid beverage.
Preferably, in step (1), the granulation is performed in a high-efficiency wet granulator, the mixing and stirring speed in the granulation is 500-.
Preferably, in the step (2), the drying temperature is 65-75 deg.C, such as 65 deg.C, 66 deg.C, 68 deg.C, 70 deg.C, 72 deg.C, 74 deg.C, 75 deg.C, etc.
Preferably, in the step (2), the total mixing is carried out in a three-dimensional mixer, and the total mixing is followed by sub-packaging by a multi-column packaging machine.
In a fifth aspect, the present invention provides a liquid beverage comprising the composition having anti-aging effect according to the first aspect.
Preferably, the liquid beverage comprises the following components in parts by weight: 10-30 parts of the composition with the anti-aging effect, 6-15 parts of fruit concentrated juice, 0.01-0.5 part of edible essence, 0.01-1 part of flavoring agent and 20-40 parts of water.
In the liquid beverage, the content of the composition having an anti-aging effect is 10 to 30 parts, and may be, for example, 10 parts, 12 parts, 14 parts, 16 parts, 18 parts, 20 parts, 22 parts, 24 parts, 26 parts, 28 parts, 30 parts, and the like.
In the liquid beverage, the content of the fruit juice concentrate is 6 to 15 parts, and may be, for example, 6 parts, 7 parts, 8 parts, 9 parts, 10 parts, 11 parts, 12 parts, 13 parts, 14 parts, 15 parts, or the like.
In the liquid beverage, the content of the edible essence is 0.01-0.5 parts, for example, 0.01 parts, 0.05 parts, 0.1 parts, 0.2 parts, 0.3 parts, 0.4 parts, 0.5 parts and the like.
The content of the flavoring agent in the liquid beverage is 0.01 to 1 part, and may be, for example, 0.01 part, 0.05 part, 0.1 part, 0.2 part, 0.3 part, 0.4 part, 0.5 part, 0.6 part, 0.8 part, 1 part, or the like.
The content of water in the liquid beverage is 20 to 40 parts, and may be, for example, 20 parts, 22 parts, 24 parts, 26 parts, 28 parts, 30 parts, 32 parts, 34 parts, 36 parts, 38 parts, 40 parts, or the like.
In a sixth aspect, the present invention provides a method for preparing a liquid beverage according to the fifth aspect, specifically comprising the following steps:
(I) mixing the composition with the anti-aging effect, the concentrated fruit juice, the edible essence, the flavoring agent and water, and sieving to obtain a material body;
(II) sterilizing the material body obtained in the step (I), and filling to obtain the liquid beverage.
Preferably, in step (I), the mixing temperature is 65-75 deg.C, such as 65 deg.C, 66 deg.C, 68 deg.C, 70 deg.C, 72 deg.C, 75 deg.C, etc., and time is 10-20min, such as 10min, 12min, 14min, 16min, 18min, 20min, etc.
Preferably, in step (I), the mesh has a pore size of 200-300 meshes, such as 200 meshes, 220 meshes, 240 meshes, 260 meshes, 280 meshes, 300 meshes, etc.
Preferably, in step (II), the sterilization is carried out using ultra-high temperature flash sterilization, UHT, technique;
preferably, in the step (II), the packaging bottle used for filling needs to be cleaned by an anion cleaning technology; and the filling is carried out by adopting a full-automatic filling machine.
The beverage prepared by the product is sterilized by UHT, is different from the conventional heating sterilization, can ensure the main active ingredients of the raw materials, and can ensure the original taste and flavor of the product in shelf life.
Compared with the prior art, the invention has the following beneficial effects:
(1) the invention provides a new application of a Schizophyllum commune fermented product, which is prepared by a fermentation process with a proprietary technology and is applied to an oral beauty product. The composition has remarkable antiaging effect;
(2) the invention researches the mechanism of the Schizophyllum commune fermentation product composition on the action of the skin with aging for the first time, and finds that the Schizophyllum commune fermentation product composition can improve the contents of hydroxyproline and hyaluronic acid in the skin, improve the activity of antioxidant enzyme of a mouse body and inhibit the secretion of inflammatory cytokines. Has obvious synergistic effect.
Detailed Description
The technical solution of the present invention is further explained by the following embodiments. It should be understood by those skilled in the art that the examples are only for the understanding of the present invention and should not be construed as the specific limitations of the present invention.
The following examples and comparative examples have the following sources of the components:
preparation example 1
The preparation example provides a schizophyllum commune fermented product, which is obtained by the following preparation method:
(A) the schizophyllum commune culture medium is prepared according to the following mass percentages: 5g/L of kudzu root powder, 0.3% of yeast extract, 0.05% of magnesium sulfate, 0.1% of monopotassium phosphate, 3% of glucose and the balance of water.
(B) Inoculating 10% Schizophyllum commune (v/v, Schizophyllum commune seed solution/total volume of culture medium after inoculating seed solution) into the above culture medium, and fermenting at 28 deg.C and 150 r/min. After fermenting for 120h, centrifuging the fermentation product, and removing thallus and radix Puerariae powder to obtain the fermentation product.
Preparation example 2
The preparation example provides an olive extract, which is prepared by the following preparation method:
(a) extracting olive raw materials by using water as a solvent through a PEF extraction method to obtain olive extracting solution; wherein the volume ratio of the olive raw material to water is 1g:20mL, the field intensity of extraction is 20kV/cm, and the pulse frequency is 8 times;
(b) filtering and concentrating the olive extracting solution obtained in the step (a) to obtain an extract; wherein, the filtration adopts a 200-mesh filter membrane, and the concentration temperature is 80 ℃;
(c) mixing the extract obtained in the step (b) with maltodextrin, and then carrying out spray drying to obtain the olive extract; wherein the mass ratio of the extract to the maltodextrin is 1:0.2, the air inlet temperature of the spray drying is 100 ℃, and the air outlet temperature is 70 ℃.
Preparation example 3
The preparation example provides a roxburgh rose extract, which is prepared by the following preparation method:
(a) extracting the roxburgh rose raw material by using water as a solvent through a PEF extraction method to obtain roxburgh rose extracting solution; wherein the mass of the roxburgh rose raw material and the volume ratio of water are 1g:10mL, the field intensity of extraction is 15kV/cm, and the pulse frequency is 6 times;
(b) filtering and concentrating the rosa roxburghii tratt extract obtained in the step (a) to obtain an extract; wherein, the filtration adopts a 300-mesh filter membrane, and the concentration temperature is 75 ℃;
(c) mixing the extract obtained in the step (b) with maltodextrin, and then carrying out spray drying to obtain the roxburgh rose extract; wherein the mass ratio of the extract to the maltodextrin is 1:0.1, the air inlet temperature of spray drying is 90 ℃, and the air outlet temperature is 70 ℃.
Preparation example 4
The preparation example provides an emblic extract, which is prepared by the following preparation method:
(a) extracting raw materials of the emblic leafflower fruits by using water as a solvent through a PEF extraction method to obtain an emblic leafflower fruit extracting solution; wherein the volume ratio of the mass of the raw material of the emblic leafflower fruit to the water is 1g:30mL, the field intensity of the extraction is 30kV/cm, and the pulse frequency is 10 times;
(b) filtering and concentrating the emblic extract obtained in the step (a) to obtain an extract; wherein, the filtration adopts a 300-mesh filter membrane, and the concentration temperature is 90 ℃;
(c) mixing the extract obtained in the step (b) with maltodextrin, and then carrying out spray drying to obtain the emblic leafflower fruit extract; wherein the mass ratio of the extract to the maltodextrin is 1:0.3, the air inlet temperature of spray drying is 120 ℃, and the air outlet temperature is 90 ℃.
Preparation example 5
The preparation example provides a blueberry extract, and the blueberry extract is prepared by the following preparation method:
(a) extracting the blueberry raw material by using water as a solvent through a PEF extraction method to obtain a blueberry extracting solution; wherein the volume ratio of the mass of the blueberry raw material to the volume of water is 1g:20mL, the field intensity of extraction is 20kV/cm, and the pulse frequency is 12 times;
(b) filtering and concentrating the blueberry extract obtained in the step (a) to obtain an extract; wherein, the filtration adopts a 200-mesh filter membrane, and the concentration temperature is 80 ℃;
(c) mixing the extract obtained in the step (b) with maltodextrin, and then carrying out spray drying to obtain the blueberry extract; wherein the mass ratio of the extract to the maltodextrin is 1:0.2, the air inlet temperature of the spray drying is 100 ℃, and the air outlet temperature is 70 ℃.
Preparation example 6
The preparation example provides a cranberry extract, and the cranberry extract is prepared by the following preparation method:
(a) extracting a cranberry raw material by using water as a solvent through a PEF extraction method to obtain a cranberry extracting solution; wherein the volume ratio of the mass of the cranberry raw material to the volume of water is 1g:20mL, the field intensity of extraction is 18kV/cm, and the pulse frequency is 10 times;
(b) filtering and concentrating the cranberry extract obtained in the step (a) to obtain an extract; wherein, the filtration adopts a 200-mesh filter membrane, and the concentration temperature is 80 ℃;
(c) mixing the extract obtained in the step (b) with maltodextrin, and then carrying out spray drying to obtain the cranberry extract; wherein the mass ratio of the extract to the maltodextrin is 1:0.2, the air inlet temperature of spray drying is 100 ℃, and the air outlet temperature is 70 ℃.
Preparation example 7
The preparation example provides a aronia melanocarpa extract, which is prepared by the following preparation method:
(a) extracting the aronia melanocarpa raw material by using water as a solvent through a PEF extraction method to obtain an aronia melanocarpa extracting solution; wherein the volume ratio of the mass of the aronia melanocarpa raw material to the water is 1g:15mL, the field intensity of extraction is 25kV/cm, and the pulse frequency is 6 times;
(b) filtering and concentrating the aronia melanocarpa extract obtained in the step (a) to obtain an extract; wherein, the filtration adopts a 300-mesh filter membrane, and the concentration temperature is 80 ℃;
(c) mixing the extract obtained in the step (b) with maltodextrin, and performing spray drying to obtain the aronia melanocarpa extract; wherein the mass ratio of the extract to the maltodextrin is 1:0.1, the air inlet temperature of spray drying is 90 ℃, and the air outlet temperature is 70 ℃.
Example 1
The embodiment provides a composition with an anti-aging effect, which comprises the following components in parts by weight: 30 parts of schizophyllum commune fermentation product provided in preparation example 1, 5 parts of olive extract provided in preparation example 2, and 10 parts of collagen peptide.
Example 2
The embodiment provides a composition with an anti-aging effect, which comprises the following components in parts by weight: 25 parts of schizophyllum commune fermentation product provided in preparation example 1, 8 parts of rosa roxburghii tratt extract provided in preparation example 3 and 12 parts of collagen peptide.
Example 3
The embodiment provides a composition with an anti-aging effect, which comprises the following components in parts by weight: 30 parts of schizophyllum commune fermentation product provided in preparation example 1, 5 parts of blueberry extract provided in preparation example 4 and 10 parts of collagen peptide.
Example 4
The embodiment provides a composition with an anti-aging effect, which comprises the following components in parts by weight: 32 parts of schizophyllum commune fermentation product provided by preparation example 1, 3 parts of blueberry extract provided by preparation example 5 and 7 parts of collagen peptide.
Example 5
The embodiment provides a composition with an anti-aging effect, which comprises the following components in parts by weight: 40 parts of schizophyllum commune fermentation product provided in preparation example 1, 3 parts of cranberry extract provided in preparation example 6, and 7 parts of collagen peptide.
Example 6
The embodiment provides a composition with an anti-aging effect, which comprises the following components in parts by weight: 20 parts of schizophyllum commune fermented product provided in preparation example 1, 10 parts of aronia melanocarpa extract provided in preparation example 7, and 16 parts of collagen peptide.
Example 7
This example provides a composition with anti-aging effect, which is different from example 1 only in that the schizophyllum commune fermented substance provided in preparation example 1 is replaced by the schizophyllum commune fermented liquid provided in example 1 in CN 107320541A.
Example 8
This example provides a composition having anti-aging effect, which is different from example 1 only in that the olive extract provided in preparation example 2 is replaced with a commercially available olive extract (manufacturer: Nippon Biopsis, cat # CB-2021091).
Comparative example 1
This comparative example provides a composition comprising, in parts by weight: 33 parts of Schizophyllum commune fermentation product and 12 parts of collagen peptide provided in preparation example 1.
Comparative example 2
This comparative example provides a composition comprising, in parts by weight: 35 parts of the Schizophyllum commune fermented product provided in preparation example 1 and 10 parts of the olive extract provided in preparation example 2.
Comparative example 3
This comparative example provides a composition comprising, in parts by weight: 20 parts of olive extract and 25 parts of collagen peptide provided in preparation example 2.
Test example 1
Ability to scavenge free radicals
Test samples: examples 1-8 provide compositions having anti-aging effects and comparative examples 1-3;
the test method comprises the following steps:
1. evaluation of superoxide anion radical scavenging ability
4.5mL of Tris-HCl buffer (0.05 mol/LpH ═ 8.2) was preheated in a water bath at 25 ℃ for 20 min. Then adding 1mL of sample and 0.4mL of 25mmol/L pyrogallol solution, mixing uniformly, reacting in a water bath at 25 ℃ for 5min, and adding 1.0mL of 8mol/L HCl to terminate the reaction. Absorbance values were measured at 299nm with Tris-HCl buffer as a reference. Blank a 1mL aliquot of solvent was used in place of the sample.
Superoxide anion radical scavenging rate (%) ([ 1- (A)2/A1)]X is 100%; in the formula A1Absorbance values for the blank; a. the2Is the absorbance value of the sample.
2. Evaluation of hydroxyl radical scavenging ability
Sequentially adding 2mmol/L FeSO into a 25mL colorimetric tube4 3mL,1mmol/L H2O23mL, shaking up, then adding 3mL of salicylic acid with the concentration of 6mmol/L, shaking up, heating in a water bath at 37 ℃ for 15min, taking out, and measuring the absorbance; adding the solutions to be tested with certain concentrations, shaking, heating in water bath for 15min, and taking out to test their absorbance. The following formula is the clearance rate of hydroxyl radical (. OH) by the liquid to be tested:
hydroxyl radical clearance (%) ═ a1-A2-(A1-A3)]/A1X is 100%; in the formula A1The absorbance value of the reaction system before adding the medicine is obtained; a. the2Removing OH from the sample to obtain the absorbance value of the system; a. the3Removing OH for blank control to obtain absorbance value of the system;
3. evaluation of scavenging ability for DPPH free radical
Test A20 mmol/L DPPH solution was prepared according to the method specified in Larrauri JA; test sample solution: the schizophyllan compositions provided in examples 1-10 and the compositions provided in comparative examples 1-5 were diluted with ultrapure water to give solutions having a mass concentration of 0.1%. Putting 2.0mL of test sample solution and 2.0mL of 20mmol/L DPPH solution in a test tube, mixing uniformly, reacting for 30min, measuring absorbance value at 517nm, taking absolute ethyl alcohol as blank control, and calculating DPPH inhibition ratio according to the absorbance value.
DPPH radical inhibition (%) - [1- (A)1-A2)/A3]X is 100%; wherein A is1Absorbance of 2.0mL of DPPH solution and 2.0mL of test sample solution, A2Absorbance of 2.0mL of the test sample solution and 2.0mL of absolute ethanol, A3The absorbance of 2.0mL of DPPH solution and 2.0mL of absolute ethyl alcohol is obtained, and the average value is obtained by parallel testing for three times;
the specific test results are shown in table 1:
TABLE 1
As shown in the test data in Table 1, the composition with the anti-aging effect has good oxidation resistance and DPPH free radical removing capacity, the superoxide anion free radical removing rate is more than 60%, the hydroxyl free radical removing rate is more than 60%, and the DPPH free radical inhibiting rate is more than 80%.
As can be seen from the comparison between example 1 and comparative examples 1-3, the three components of the composition with anti-aging effect cooperate with each other to have a synergistic effect, so that the scavenging effect of the composition on DPPH free radicals, hydroxyl free radicals and superoxide anion free radicals can be further improved, the anti-oxidation capability of skin tissues can be enhanced, and the free radical content of the skin tissues can be reduced.
Test example 2
Detection of hydroxyproline
Test samples: examples 1-8 provide compositions having anti-aging effects and comparative examples 1-3;
the test method comprises the following steps:
1. preparing human skin cells
Taking dermal fibroblast of normal human as primary cell at 75cm2In a culture flask (2 mL of growth factor-containing medium), CO at 37 ℃2Cells were cultured at a concentration of 5% to a concentration of 80%. Passage is carried out, and the passage cell is 175cm2The cells were continued to culture to 80% concentration in the flask.
2. Preparation of samples to be tested
Culturing human dermal fibroblasts obtained by the previous step in a DMEM culture solution containing 10% fetal calf serum at 37 ℃ for 24 hours in 5% CO2, digesting the cells with a digestive juice containing 0.25% trypsin and 0.02% EDTA after the cells are nearly fused, and then carrying out passage 1:2 to select fourth generation cells;
cells were diluted to density of 10 with DMEM medium containing 10% fetal bovine serum5One cell/mL, and then inoculated into 12-well plates at an inoculum size of 2X 105Culturing each cell/well until the cells are nearly 80% fused, washing the plate with physiological saline for 3 times, adding the sample to be tested (0.1 mL of the above sample + 0.2mL of physiological saline) and the control sample (0.3mL of physiological saline) into each well, and culturing at 37 deg.C with 5% CO2Under the condition of culturingAfter day, culture supernatants of the test sample and the control sample were collected for use.
3. Determination of hydroxyproline content
According to a human hydroxyproline enzyme-linked immunoassay kit (Shanghai enzyme-linked biosciences, Ltd.), hydroxyproline content determination of culture supernatants of a sample to be tested and a control group sample is carried out:
(1) drawing a hydroxyproline standard curve, and preparing 6 hydroxyproline standard solutions, wherein the concentrations are as follows in sequence: 0 mu g/mL, 3 mu g/mL, 6 mu g/mL, 12 mu g/mL, 24 mu g/mL, 48 mu g/mL, and testing the OD value of the sample at the wavelength of 450nm by using an enzyme labeling instrument;
(2) according to the result of the absorbance test of the hydroxyproline standard, drawing a hydroxyproline standard curve by taking the absorbance as a vertical axis and the concentration of hydroxyproline as a horizontal axis;
(3) diluting the culture supernatants of the sample to be detected and the control group sample by 5 times by using a solvent in the kit, determining the absorbance of the culture supernatants of the sample to be detected and the control group sample diluted by 5 times at the wavelength of 450nm according to the specification of a human hydroxyproline enzyme-linked immunoassay kit, and calculating the content of hydroxyproline generated by fibroblasts in the culture supernatants of the sample to be detected and the control group sample according to a drawn hydroxyproline concentration standard curve;
the specific test results are shown in table 2:
TABLE 2
As can be seen from the test data in Table 2, the content of hydroxyproline is obviously increased after the composition with the anti-aging effect is added, the content of hydroxyproline is more than 34 mu g/mL, and the increase rate is more than 25% compared with that of a control group. The composition with the anti-aging effect can obviously improve the amount of collagen secreted by fibroblasts of the skin.
Test example 3
Detection of hyaluronic acid
Test samples: examples 1-8 provide compositions having anti-aging effects and comparative examples 1-3 provide compositions;
the test method comprises the following steps:
measurement of hydroxyproline content in the culture supernatants of each test sample and control sample in test example 2 according to a human hyaluronic acid enzyme-linked immunoassay kit (shanghai enzyme-linked biotechnology limited):
1. drawing a hyaluronic acid standard curve; preparing 6 hyaluronic acid standard substance solutions, wherein the concentrations are as follows in sequence: 0. mu.g/mL, 10. mu.g/mL, 20. mu.g/mL, 40. mu.g/mL, 80. mu.g/mL, 160. mu.g/mL, and the OD value thereof was measured at 450nm using a microplate reader,
2. according to the test result of the hyaluronic acid standard product, drawing a standard curve of hyaluronic acid by taking the absorbance as a vertical axis and taking the concentration of hyaluronic acid as a horizontal axis;
(3) diluting the culture supernatants of the sample to be detected and the control group sample by 5 times by using a solvent in the kit, and calculating the content of hyaluronic acid according to the OD value of the culture supernatants of the human hyaluronic acid enzyme-linked immunoassay kit;
the specific test results are shown in table 3:
TABLE 3
As shown in the test data in Table 2, the content of hyaluronic acid is obviously increased after the composition with the anti-aging effect is added, the content of hyaluronic acid is more than 185 mu g/mL, and the increase rate is more than 40% compared with a control group. The composition with the anti-aging effect can obviously improve the amount of hyaluronic acid secreted by skin fibroblasts, improve the water locking capacity of the skin and keep the skin moist.
Test example 4
Influence on the Activity of antioxidant enzymes in mouse serum
Test samples: examples 1-8 provide compositions having anti-aging effects and comparative examples 1-3;
the test method comprises the following steps:
1. laboratory animal
12-month old SPF-grade healthy mice, female and male half.
2. Experimental methods
Randomly dividing 12-month-old SPF-grade healthy mice into 12 groups, wherein each group comprises 10 mice; wherein 11 groups respectively fed 2.0g/kg per day of the corresponding group of examples 1 to 8 and comparative examples 1 to 3, respectively, in addition to the normal feeding of the conventional feeds, provided the compositions having anti-aging effects; wherein, 1 group is used as control group and is fed with conventional feed normally; after feeding each group continuously for 30 days, the mice were sacrificed and then serum Malondialdehyde (MDA), reduced glutathione content (GSH), and antioxidant enzyme activity were measured in vivo.
3. Statistical treatment
Statistical processing was performed using SPSS11.0 statistical software, data were measured to represent one-way analysis of variance using multiple sample mean comparisons, and count data were tested using x 2.
4. Results of the experiment
Three positive indexes of the four indexes of lipid oxidation products, protein oxidation products, antioxidase and antioxidant substances can determine that the animal experiment result of the antioxidant function of the tested sample is positive.
The specific test results are shown in table 4:
TABLE 4
As can be seen from the test data in Table 4, the MDA level in the serum of the mice taking the composition with the anti-aging effect is remarkably reduced, and the GSH content, the SOD activity and the GSH-Px activity of the antioxidant substances are remarkably increased, wherein the MDA content is less than 4.5mmol/L, the GSH content is more than 5.6mmol/L, the SOD content is more than 280 mu/mL, and the GSH-Px content is more than 200 mu/mL. The composition with the anti-aging effect has good anti-oxidation and health-care effects.
Test example 5
Inhibition of inflammatory cytokine secretion
Test samples: examples 1-8 provide compositions having anti-aging effects and comparative examples 1-3;
the test principle is as follows: "proinflammatory cytokine (proinflammatory cytokine)" refers to a series of cytokines that promote inflammation, and plays an important role in acute inflammatory response, increasing vascular permeability, and causing red, swelling, heat, pain and other inflammatory responses. The more common proinflammatory cytokines include tumor necrosis factor alpha (TNF-alpha), interleukin 6(interleukin-6, IL-6) and interleukin 12(interleukin-12, IL-12), etc., so that the inhibition of these cytokines can also contribute to the reduction of the inflammatory symptoms of certain diseases;
the test method comprises the following steps:
1. test materials: LPS was purchased from Sigma; FBS was purchased from PAA, USA; DMEM high glucose medium; ELISA kits were purchased from biolignd, usa.
2. Animals: c57BL/6 mice, purchased from Beijing Huafukang Biotech GmbH.
3. Experimentally RAW264.7 cells were plated at 3X 105cells/well concentration seeded in 96-well microtiter plates at 37 ℃ 5% CO2Culturing in an incubator. After 24 hours of incubation, 1. mu.g/mL LPS and sample were added, respectively, followed by 5% CO at 37 ℃2The culture was carried out in an incubator for 24 hours, in which samples were supplied to the composition having antiaging action according to examples 1 to 8 and the composition according to comparative examples 1 to 3, respectively (sample concentration of 50. mu.g/mL).
After the culture, the culture solution is sucked out, the expression quantity of the proinflammatory cytokines such as TNF-alpha, IL-6, IL-12 and the like is analyzed by using an ELISA kit, and the inhibition rate of the proinflammatory cytokine production of the sample is calculated according to the following formula:
inhibition rate (%) of proinflammatory cytokine production [1-C1/C0]×100%;
Wherein, C0Represents the concentration of proinflammatory cytokine production with addition of the inducer LPS alone, C1Represents the concentration of proinflammatory cytokines produced when the inducer LPS is added simultaneously with the sample;
the specific test results are shown in table 5:
TABLE 5
As can be seen from the data tested in Table 5, LPS stimulated the activation of BMDM cells, which was shown to secrete a number of inflammatory cytokines TNF- α, IL-6, IL-12. The composition with the anti-aging effect can obviously inhibit the secretion of TNF-alpha, IL-6 and IL-12, and has an inhibition rate of more than 20 percent for TNF-alpha, more than 50 percent for IL-6 and more than 30 percent for IL-12.
Application example 1
The application example provides a solid beverage, which comprises the following components in parts by weight:
name (R) | Proportioning parts |
Example 1 provides compositions with anti-aging action | 30 |
Flavoring agent | 0.5 |
Edible essence | 1 |
Maltodextrin | 20 |
The preparation method of the solid beverage comprises the following steps:
(1) placing the olive extract and maltodextrin in a high-efficiency wet granulator to carry out wet mixing for 6min, and controlling the mixing and stirring speed to be 150 r/min; then adding Schizophyllum commune fermented product, mixing for 5min, granulating, and controlling the rotation speed of granulating slurry to 800 r/min;
(2) drying the prepared granular material by a fluidized bed to obtain a granular mixture, and controlling the drying temperature to be 70 ℃; then putting the particle mixture, the collagen powder, the sweetener and the edible essence into a three-dimensional mixer for total mixing to obtain a mixture; and finally, subpackaging the total mixed powder by using a multi-row subpackaging machine to control the net content of the product.
Application examples 2 to 8
The present application example provides different solid beverages, differing from application example 1 only in that the composition having an antiaging effect provided in example 1 was replaced with the corresponding composition having an antiaging effect provided in examples 2 to 8.
Comparative application examples 1 to 3
Comparative application example different solid beverages were provided, differing from application example 1 only in that the composition with anti-ageing effect provided in example 1 was replaced by the corresponding compositions provided in comparative examples 1 to 3.
Application example 9
The application example provides a liquid beverage, which comprises the following components in parts by weight:
name (R) | Proportioning parts |
Example 1 provides compositions with anti-aging action | 20 |
Fruit concentrated juice | 10 |
Edible essence | 0.2 |
Flavoring agent | 0.1 |
Purified water | 30 |
The preparation method of the liquid beverage comprises the following steps:
(I) preparation: putting the composition with the anti-aging effect, the fruit concentrated juice, the edible essence and the flavoring agent, which are provided by the embodiment 1, into a preparation tank, adding purified water with the formula amount, controlling the temperature at 70 ℃, stirring for 15min until the mixture is uniformly mixed, and then sieving the mixture into a storage tank;
(II) sterilizing the prepared material body by adopting an ultrahigh temperature instantaneous sterilization UHT technology; the inner packaging bottle is cleaned by adopting an anion cleaning technology; and (4) subpackaging the liquid by adopting a full-automatic filling machine.
Application examples 10 to 16
This application example provides different liquid beverages, differing from application example 9 only in that the composition with anti-aging effect provided in example 1 was replaced with the corresponding composition with anti-aging effect provided in examples 2 to 8.
Comparative application examples 4 to 6
Comparative application example different liquid beverages were provided, differing from application example 1 only in that the composition with anti-ageing effect provided in example 1 was replaced by the corresponding compositions provided in comparative examples 1 to 3.
Test example 6
Test for anti-aging Properties
Test samples: examples 1-8 provide compositions having anti-aging effects and comparative examples 1-3 provide compositions;
test methods (zebrafish SA- β -gal staining experiment):
after the zebra fish in the test group or the blank group is dyed, an image is captured and collected by a microscope, all the images uniformly adopt the same shooting parameters including body position, magnification factor, light intensity, absorbance, exposure setting (each sample is respectively exposed for 5ms, 15ms and 30ms, three pictures are shot) and the like, and the acquired image of the zebra fish SA-beta-gal dyeing effect shows that the SA-beta-gal dyeing positive rate of the zebra fish is visually reduced compared with that of the blank control group after the test group is respectively treated by different samples through microscopic imaging.
To ensure comparability, then adopting Image analysis soft Image Pro Plus to respectively obtain a lateral fish body area value (S) and a staining integral optical density value (IOD), and calculating the ratio IOD/S of the lateral fish body area value (S) and the staining integral optical density value (IOD);
the specific test results are shown in table 6:
TABLE 6
As shown in the test data in Table 6, the SA-beta-gal staining positive rate is low in the test group compared with the blank group, and the difference is statistically significant (P < 0.05). The composition with the anti-aging effect can reduce the dyeing positive rate of SA-beta-gal staining of the zebra fish under a proper proportion concentration, and can effectively interfere the aging of embryonic developmental cells of the zebra fish and delay the aging process of the zebra fish, thereby proving that the composition with the anti-aging effect has the anti-aging effect.
The applicant states that the composition with anti-aging effect and the application thereof of the present invention are illustrated by the above examples, but the present invention is not limited to the above examples, that is, the present invention is not meant to be necessarily dependent on the above examples for implementation. It should be understood by those skilled in the art that any modification of the present invention, equivalent substitutions of the raw materials of the product of the present invention, addition of auxiliary components, selection of specific modes, etc., are within the scope and disclosure of the present invention.
Claims (10)
1. A composition with anti-aging effect, which is characterized by comprising the following components: schizophyllum commune fermented product, plant extract and collagen peptide.
2. The composition with anti-aging effect according to claim 1, characterized by comprising the following components in parts by weight: 20-40 parts of schizophyllum commune fermentation product, 3-10 parts of plant extract and 7-16 parts of collagen peptide.
3. The composition with anti-aging effect according to claim 1 or 2, wherein the Schizophyllum commune fermented product is a Schizophyllum commune fermented product obtained by culturing Schizophyllum commune in a medium containing radix Puerariae.
4. The composition with an anti-aging effect according to any one of claims 1 to 3, wherein the plant extract comprises any one of or a combination of at least two of olive extract, rosa roxburghii extract, emblica officinalis extract, blueberry extract, cranberry extract and aronia melanocarpa extract.
5. The composition with anti-aging effect according to any one of claims 1 to 4, wherein the plant extract is obtained by PEF extraction;
preferably, the plant extract is prepared by the following preparation method:
(a) extracting the plant raw materials by using water as a solvent through a PEF extraction method to obtain a plant extracting solution;
(b) filtering and concentrating the plant extract obtained in the step (a) to obtain an extract;
(c) mixing the extract obtained in the step (b) with maltodextrin, and performing spray drying to obtain the plant extract;
preferably, in the step (a), the mass volume ratio of the plant raw material to the water is 1 (10-30) g/mL;
preferably, in the step (a), the field intensity of the extraction is 10-30kV/cm, and the pulse number of the extraction is 4-12 times;
preferably, in the step (b), a 200-mesh and 300-mesh filter membrane is adopted for filtration;
preferably, in step (b), the temperature of the concentration is 70-90 ℃;
preferably, in the step (c), the mass ratio of the extract to the maltodextrin is 1 (0.05-0.4);
preferably, in the step (c), the inlet air temperature of the spray drying is 85-120 ℃, and the outlet air temperature is 65-90 ℃.
6. Use of the composition having an antiaging effect as claimed in any one of claims 1 to 5 for producing a health food;
preferably, the health food comprises a solid beverage and/or a liquid beverage.
7. A solid beverage comprising the composition having an antiaging effect according to any one of claims 1 to 5;
preferably, the solid beverage comprises the following components in parts by weight: 20-40 parts of the composition with the anti-aging effect, 0-1 part of a flavoring agent, 0-4.5 parts of edible essence and 15-30 parts of maltodextrin.
8. A method for preparing a solid beverage according to claim 7, comprising the following steps:
(1) mixing the plant extract and maltodextrin, mixing with Schizophyllum commune fermented product, and granulating to obtain granule mixture;
(2) drying the particle mixture obtained in the step (1), and then totally mixing the particle mixture with collagen peptide, optional flavoring agent and optional edible essence to obtain the solid beverage;
preferably, in the step (1), the granulation is performed in a high-efficiency wet granulator, the mixing and stirring speed in the granulation is 500-1000r/min, and the mixing time is 3-5 min;
preferably, in the step (2), the drying temperature is 65-75 ℃;
preferably, in the step (2), the total mixing is performed in a three-dimensional mixer, and the total mixing further comprises sub-packaging by a multi-row racking machine.
9. A liquid beverage comprising the composition having an anti-aging effect according to any one of claims 1 to 5;
preferably, the liquid beverage comprises, in parts by weight: 10-30 parts of the composition with the anti-aging effect, 6-15 parts of fruit concentrated juice, 0.01-0.5 part of edible essence, 0.01-1 part of flavoring agent and 20-40 parts of water.
10. A method for preparing a liquid beverage according to claim 9, characterized in that it comprises in particular the steps of:
(I) mixing the composition with the anti-aging effect, the concentrated fruit juice, the edible essence, the flavoring agent and water, and sieving to obtain a material body;
(II) sterilizing the material body obtained in the step (I), and filling to obtain the liquid beverage;
preferably, in the step (I), the temperature of the mixing is 65-75 ℃ and the time is 10-20 min;
preferably, in step (I), the aperture of the screen is 200-300 meshes;
preferably, in step (II), the sterilization is carried out using ultra-high temperature flash sterilization, UHT, technique;
preferably, in the step (II), the packaging bottle used for filling needs to be cleaned by an anion cleaning technology; and the filling is carried out by adopting a full-automatic filling machine.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202210160671.9A CN114521652A (en) | 2022-02-22 | 2022-02-22 | Composition with anti-aging effect and application thereof |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202210160671.9A CN114521652A (en) | 2022-02-22 | 2022-02-22 | Composition with anti-aging effect and application thereof |
Publications (1)
Publication Number | Publication Date |
---|---|
CN114521652A true CN114521652A (en) | 2022-05-24 |
Family
ID=81625367
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202210160671.9A Pending CN114521652A (en) | 2022-02-22 | 2022-02-22 | Composition with anti-aging effect and application thereof |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN114521652A (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN115161204A (en) * | 2022-07-22 | 2022-10-11 | 陕西森盛菌业科技有限公司 | Culture method and culture medium of armillaria mellea for gastrodia elata planting symbiosis |
Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN106173661A (en) * | 2016-07-13 | 2016-12-07 | 淮南恒天生物科技有限公司 | A kind of composite bacteria mixed fermentation drinks and preparation method thereof |
CN110507582A (en) * | 2019-09-23 | 2019-11-29 | 中国科学院烟台海岸带研究所 | A kind of anti-ageing remediation composition and its preparation method and application containing composite vegetables extractive |
CN111297791A (en) * | 2020-02-26 | 2020-06-19 | 广州留今科学研究有限公司 | Anti-aging and repairing skin care composition containing symbiotic bacteria combined fermentation product, essence milk and preparation method and application of essence milk |
US20200352206A1 (en) * | 2019-05-08 | 2020-11-12 | Christine Wagner-Salvini | Composition and method for mushroom mycelial compound and botanical mixture |
CN113337545A (en) * | 2021-06-03 | 2021-09-03 | 广东丸美生物技术股份有限公司 | Schizophyllum commune fermentation product, preparation method thereof, skin care product and schizophyllum commune culture medium |
CN113975217A (en) * | 2021-12-02 | 2022-01-28 | 广东丸美生物技术股份有限公司 | Whitening and anti-aging composition based on herbaceous plants and preparation method and application thereof |
-
2022
- 2022-02-22 CN CN202210160671.9A patent/CN114521652A/en active Pending
Patent Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN106173661A (en) * | 2016-07-13 | 2016-12-07 | 淮南恒天生物科技有限公司 | A kind of composite bacteria mixed fermentation drinks and preparation method thereof |
US20200352206A1 (en) * | 2019-05-08 | 2020-11-12 | Christine Wagner-Salvini | Composition and method for mushroom mycelial compound and botanical mixture |
CN110507582A (en) * | 2019-09-23 | 2019-11-29 | 中国科学院烟台海岸带研究所 | A kind of anti-ageing remediation composition and its preparation method and application containing composite vegetables extractive |
CN111297791A (en) * | 2020-02-26 | 2020-06-19 | 广州留今科学研究有限公司 | Anti-aging and repairing skin care composition containing symbiotic bacteria combined fermentation product, essence milk and preparation method and application of essence milk |
CN113337545A (en) * | 2021-06-03 | 2021-09-03 | 广东丸美生物技术股份有限公司 | Schizophyllum commune fermentation product, preparation method thereof, skin care product and schizophyllum commune culture medium |
CN113975217A (en) * | 2021-12-02 | 2022-01-28 | 广东丸美生物技术股份有限公司 | Whitening and anti-aging composition based on herbaceous plants and preparation method and application thereof |
Non-Patent Citations (1)
Title |
---|
邴雪等: "裂褶菌液体培养条件优化及其发酵液功效检测", 《食用菌》 * |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN115161204A (en) * | 2022-07-22 | 2022-10-11 | 陕西森盛菌业科技有限公司 | Culture method and culture medium of armillaria mellea for gastrodia elata planting symbiosis |
CN115161204B (en) * | 2022-07-22 | 2024-04-05 | 陕西森盛菌业科技有限公司 | Culture method and culture medium of armillaria mellea for gastrodia elata planting symbiosis |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN111772195B (en) | Giant salamander collagen peptide, preparation method and preparation thereof | |
KR101467903B1 (en) | The preparing method of immune improving agents | |
CN104593219A (en) | Fermented kiwi fruit vinegar and brewing method thereof | |
CN104664384A (en) | Preparation method and application of black garlic fermentation liquid | |
CN110973342B (en) | Apostichopus japonicus oligopeptide and preparation method and application thereof | |
CN114521652A (en) | Composition with anti-aging effect and application thereof | |
CN115678805A (en) | Preparation method and application of tricholoma matsutake yeast fermentation liquor with repairing and anti-aging effects | |
CN110616122A (en) | Cardamine hupingshanensis selenium-rich yellow wine and production method thereof | |
CN100387704C (en) | Lucid ganoderma fungus with high glycopeptide composite yield, its mutagen breeding method and use | |
CN103103103B (en) | Raspberry beverage and processing method thereof | |
CN1030145C (en) | Preparation method of | |
CN111387489A (en) | Lactobacillus bird's nest product and preparation method thereof | |
CN110547384A (en) | small yellow croaker ossein antibacterial peptide and application thereof | |
CN1276723C (en) | Water soluble royal jelly and its dry powder and method for preparing them | |
KR20090042355A (en) | The preparing method of functional omija vinegar | |
CN113440455B (en) | Application of highland barley fermentation liquor | |
CN111990652A (en) | Ganoderma lucidum collagen peptide powder and preparation method thereof | |
CN105886324B (en) | A kind of Selenium-enriched fermentation method of indole-3-carbinol and indole -3-acetonitrile in raising fruit vinegar | |
CN107736524B (en) | Celery whole-pulp lactobacillus beverage and preparation method thereof | |
KR102642230B1 (en) | Composition for the treatment of asthma, comprising purified fractions of fermented black rice bran as an active ingredient | |
CN108420058A (en) | A kind of cactus gingko ferment and preparation method thereof | |
KR102642232B1 (en) | Composition for the treatment of asthma, comprising purified fractions of fermented bellflower as an active ingredient | |
CN116463183B (en) | Tartary buckwheat health wine blended with pleurotus eryngii and preparation method thereof | |
CN118006715A (en) | Method for preparing antioxidant peptide by fermenting chicken bones through microorganisms and application of antioxidant peptide | |
KR20110049349A (en) | Method for producing fermented mixed grains with fermented microorganisms alive and fermented mixed grains produced by the same |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination |